Skip to main content

letter

. 1997 Dec;50(6):329. doi: 10.1136/mp.50.6.329-a

p53 mutations in multiple myeloma.

S Paydaś, B Sahin, E Seyrek, S Zorludemir

PMCID: PMC379669 PMID: 9536285

329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Boccadoro M. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia. 1994 May;8(5):758–767. [PubMed] [Google Scholar]
Mazars G. R., Portier M., Zhang X. G., Jourdan M., Bataille R., Theillet C., Klein B. Mutations of the p53 gene in human myeloma cell lines. Oncogene. 1992 May;7(5):1015–1018. [PubMed] [Google Scholar]
Neri A., Baldini L., Trecca D., Cro L., Polli E., Maiolo A. T. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood. 1993 Jan 1;81(1):128–135. [PubMed] [Google Scholar]
Owen R. G., Davis S. A., Randerson J., Rawstron A. C., Davies F., Child J. A., Jack A. S., Morgan G. J. p53 gene mutations in multiple myeloma. Mol Pathol. 1997 Feb;50(1):18–20. doi: 10.1136/mp.50.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
Portier M., Molès J. P., Mazars G. R., Jeanteur P., Bataille R., Klein B., Theillet C. p53 and RAS gene mutations in multiple myeloma. Oncogene. 1992 Dec;7(12):2539–2543. [PubMed] [Google Scholar]
Preudhomme C., Facon T., Zandecki M., Vanrumbeke M., Laï J. L., Nataf E., Loucheux-Lefebvre M. H., Kerckaert J. P., Fenaux P. Rare occurrence of P53 gene mutations in multiple myeloma. Br J Haematol. 1992 Jul;81(3):440–443. doi: 10.1111/j.1365-2141.1992.tb08253.x. [DOI] [PubMed] [Google Scholar]
Prokocimer M., Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood. 1994 Oct 15;84(8):2391–2411. [PubMed] [Google Scholar]

ACTIONS

RESOURCES